Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Warren

Showing results (591-600 of 910) with videos related to

Pageof 91
Sort By:
Dermatology and Therapy|November 1, 2024
Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysisRichard B Warren, Kerry Donnelly, Sandeep Kiri, et al.
Journal of Cardiovascular Pharmacology|July 1, 1992
Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humansJ B Warren, J R Cockcroft, S W Larkin, et al.
Molecular Pharmaceutics|October 6, 2017
Computational Models of the Intestinal Environment. 3. The Impact of Cholesterol Content and pH on Mixed Micelle ColloidsEstelle J A Suys, Dallas B Warren, Christopher J H Porter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 30, 2021
Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trialR B Warren, M Lebwohl, H Sofen, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|September 17, 2025
Catheter-Directed Bivalirudin for Local Anticoagulation and Clot Dissolution in Children Requiring Mechanical Circulatory SupportNadia Chaudhry-Waterman, Timothy Q Schardt, Rhynn M Soderstrom, et al.
Ostomy/Wound Management|May 2, 2000
Therapeutic and financial outcomes using a pulsating low-air-loss surface for patients surviving severe posterior burnsD R Yarbrough, T E Philbeck, F M Simmons, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 18, 2015
A novel mutation in IL36RN underpins childhood pustular dermatosisJ M Ellingford, G C M Black, T H Clayton, et al.
Dermatology and Therapy|July 14, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 TrialsRichard B Warren, Alice B Gottlieb, Joseph F Merola, et al.
Plos One|August 15, 2019
Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI responseLaura M Sawyer, Kinga Malottki, Celia Sabry-Grant, et al.
JAMA Dermatology|June 4, 2025
Adalimumab Monotherapy vs Adalimumab With Methotrexate for PsoriasisZenas Z N Yiu, Catherine H Smith, Philip Laws, et al.
Pageof 91

Showing results (591-600 of 910) with videos related to

Sort By:
Pageof 91
Dermatology and Therapy|November 1, 2024
Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysisRichard B Warren, Kerry Donnelly, Sandeep Kiri, et al.
Journal of Cardiovascular Pharmacology|July 1, 1992
Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humansJ B Warren, J R Cockcroft, S W Larkin, et al.
Molecular Pharmaceutics|October 6, 2017
Computational Models of the Intestinal Environment. 3. The Impact of Cholesterol Content and pH on Mixed Micelle ColloidsEstelle J A Suys, Dallas B Warren, Christopher J H Porter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 30, 2021
Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trialR B Warren, M Lebwohl, H Sofen, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|September 17, 2025
Catheter-Directed Bivalirudin for Local Anticoagulation and Clot Dissolution in Children Requiring Mechanical Circulatory SupportNadia Chaudhry-Waterman, Timothy Q Schardt, Rhynn M Soderstrom, et al.
Ostomy/Wound Management|May 2, 2000
Therapeutic and financial outcomes using a pulsating low-air-loss surface for patients surviving severe posterior burnsD R Yarbrough, T E Philbeck, F M Simmons, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 18, 2015
A novel mutation in IL36RN underpins childhood pustular dermatosisJ M Ellingford, G C M Black, T H Clayton, et al.
Dermatology and Therapy|July 14, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 TrialsRichard B Warren, Alice B Gottlieb, Joseph F Merola, et al.
Plos One|August 15, 2019
Assessing the relative efficacy of interleukin-17 and interleukin-23 targeted treatments for moderate-to-severe plaque psoriasis: A systematic review and network meta-analysis of PASI responseLaura M Sawyer, Kinga Malottki, Celia Sabry-Grant, et al.
JAMA Dermatology|June 4, 2025
Adalimumab Monotherapy vs Adalimumab With Methotrexate for PsoriasisZenas Z N Yiu, Catherine H Smith, Philip Laws, et al.
Pageof 91